NCT02013349View on ClinicalTrials.gov

DESolve Post-Approval Study

NACompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

April 22, 2014

Primary Completion Date

October 31, 2015

Study Completion Date

April 1, 2019

Conditions
Coronary Artery Disease
Interventions
DEVICE

coronary intervention

Trial Locations (7)

11152

Jordan Hospital, Amman

20132

Ospendale San Raffaele, Milan

22110

King Abdullah University Hospital, Irbid

23795

Herz-Kreislaufzentrum Bad Segeberg, Bad Segeberg

35392

Universitätsklinikum Giessen und Marburg GmbH, Giessen

48149

Universitätsklinikum Münster, Münster

54292

Krankenhaus der Barmherzigen Brüder, Trier

Sponsors
All Listed Sponsors
lead

Elixir Medical Corporation

INDUSTRY

NCT02013349 - DESolve Post-Approval Study | Biotech Hunter | Biotech Hunter